CARLSBAD, Calif., May 13 /PRNewswire-FirstCall/ -- BIOPRO Technology, a division of FemOne, Inc. (BULLETIN BOARD: FEMO) , a publicly held Nevada Corporation, officially launched its BIOPRO technology division in Canada during a two day seminar held in Toronto, Canada on May 8-9, 2004. It was the first event of several major events to be held throughout North America.
“The Canadian business opportunity seminar was for Sales Consultants, Prospects and Customers. Over 100 people attended the 2-day event. We are extremely excited about the tremendous interest the event generated,” noted the company’s Founder and Chairman, Ray W. Grimm who was one of the speakers at the event.
One of the highlights of the event was live testing performed by Dr. Michael Rahman, demonstrating the neutralizing effects of the BIOPRO cell-chip on Electromagnetic Frequency (EMF) emitted by cell-phones. “The efficacy of the BIOPRO cell-chip was demonstrated live to the group of seminar attendees, using the original German testing device. Every one of the 5 individuals tested live demonstrated a beneficial/favorable response to the BIOPRO cell chip, despite them being under strenuous circumstances,” notes Dr. Michael Rahman, who administered the tests.
In addition to the live testing, new sales consultants went through extensive training with CEO, Ray Grimm, who directed seminars along with Lynda Cormier, BIOPRO’s National Sales Director and Steven Page, CEO of BIOPRO Canada.
“Based on the success of this event, we are already in the process of planning for another, even larger seminar in the next few months. We feel we have the most exciting new business opportunity to hit the Direct Selling Industry in a long time. The feedback we received this past weekend only supports that notion. We are very excited about what’s happening,” noted the President of BIOPRO Canada, Steven Page.
About FemOne, Inc.
FemOne, Inc. (BULLETIN BOARD: FEMO) is a Carlsbad, California based direct-selling company with distribution in the United States and Canada. More information about FemOne and its products can be found on the company’s web site at http://www.femone.com/, or by calling FemOne Inc. at (760) 448-2498. You may also contact investor relations at FEMO@investorgrowth.com or at (760) 944-7582.
Any statements made in this press release which are not historical facts contain certain forward-looking statements, as such term is defined in the Private Litigation Reform Act of 1995, concerning potential developments affecting the business, prospects, financial condition and other aspects of the company to which this release pertains. The actual results of the specific items described in this release, and the company’s operations generally, may differ materially from what is projected in such forward-looking statements. Although such statements are based upon the best judgments of management of the company as of the date of this release, significant deviations in magnitude, timing and other factors may result from business risks and uncertainties including, without limitation, the company’s dependence on third parties, general market and economic conditions, technical factors, the availability of outside capital, receipt of revenues and other factors, many of which are beyond the control of the company. The company disclaims any obligation to update information contained in any forward-looking statement.
These forward looking statements involve known and unknown risks, uncertainties and other factors that may cause our actual results, levels of activity, performance, or achievements to be materially different from any future results, levels of activity, performance, or achievement expressed or implied by such forward looking statements. In some cases, you can identify forward looking statements by terminology such as “may,” “will,” “should,” “could,” “intend,” “expects,” “plan,” “anticipates,” “believes,” “estimates,” “predicts,” “potential,” or “continue” or the negative of such terms or other comparable terminology. Although we believe that the expectations reflected in the forward looking statements are reasonable, we cannot guarantee future results, levels of activity, performance, or achievements. Moreover, neither we nor any other person assumes responsibility for the accuracy and completeness of such statements.”
FemOne, Inc.
CONTACT: Investor Relations of FemOne, Inc., +1-760-944-7582,FEMO@investorgrowth.com, or FemOne, Inc., +1-760-448-2498
Web site: http://www.femone.com/
